Mar 23, 2020
Ketamine Therapy Essential Service During COVID-19 Pandemic
Feb 10, 2020
NeuroRx: Phase 3 Drug for Suicidal Bipolar Depression to Present at BIO CEO Conference
Oct 29, 2019
ENA Applauds Introduction of ED Suicide Screening Legislation in Congress
Oct 08, 2019
CT Psychiatrist Shows Titrated IV Ketamine Can STOP Suicidality
Oct 02, 2019
Janssen Submits Supplemental New Drug Application to U.S. FDA for SPRAVATO® (esketamine) CIII Nasal Spray for the Rapid Reduction of Depressive Symptoms in Adults with Major Depressive Disorder Who Have Active Suicidal Ideation with Intent
Sep 09, 2019
NeuroRX to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
Sep 09, 2019
Over a quarter of Canadian men fear discussing mental health at work could risk their job
Aug 28, 2019
Discovery Mood and Anxiety Program Opens Treatment Program For Youth In Orlando
Jun 03, 2019
NeuroRX to Present Phase 2 Efficacy Data for NRX-101 at 2019 BIO International Convention
May 18, 2019
New Real-World Evidence Highlights Need for Interventions to Improve Outcomes for Patients Who Have Been Diagnosed with Major Depressive Disorder (MDD) and Suicide Ideation or Attempt
Nov 09, 2018
'Letters From Generation Rx' Film Exposes Psych-Drug Induced Violence and Suicide Through Heart-Wrenching Personal Stories
Oct 09, 2018
/R E P E A T -- Media Advisory - CMA to release results of new National Physician Health Survey/
Sep 20, 2018
STARR Coalition Collaborates with Evolution Research Group to Launch STARR 911--A Model for Researchers to Engage in Suicide Prevention
Jul 10, 2018
Family Recovery Centers Opens Intensive Outpatient Program in St. Charles in Response to Increased Need for Adolescent Mental Health Treatment
Apr 16, 2018
Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality
Jan 03, 2018
NeuroRx Retains J.P. Morgan as Financial Advisor
Dec 27, 2017
NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)